Medicine and Health Sciences Commons^™

Stigmatized And Getting High, Emma M. Murphy

SURGE

The first time I was asked to sell my medication was after a small party sophomore year. I was starting to fall asleep in the midst of chattering people and drunken laughter. My 12 hours of focus was up. Concerned people around me started asking why I was suddenly so sleepy and without thinking about it, my boyfriend answered “Her medication has worn off, so she’s getting kinda sleepy.” Someone asked, “What type of medication does that?!” We both froze. [excerpt]

Attention, Hyperactivity, And Cognitive Performance In Adults With Attention-Deficit/Hyperactivity Disorder (Adhd), Brianna Elizabeth Pollock

Masters Theses

The extent to which Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms (i.e., inattention, hyperactivity/impulsivity) are associated with ADHD-related cognitive impairments has yet to be understood. This study sought to examine between-group differences in activity level, performance on a sustained attention task and objectively measured attention, while controlling for anxiety and depression severity in a sample of adults with and without ADHD (N = 26). High precision actigraphs and behavioral codes of visual attention to task were used to examine the extent to which activity level and visual attention to task are related to performance on a sustained attention task (i.e., Continuous Performance …

The Impact Of An Omega-3 Enriched Diet On Hyperactivity And Biochemistry In An Animal Model For Attention-Deficit/Hyperactivity Disorder, Nadine M. Hammoud

Open Access Theses

Attention-deficit/hyperactivity disorder (ADHD) is the most diagnosed behavioral disorder in children. It affects around 5% of children worldwide and 11% of children in the United States, with rates increasing. Pharmaceutical treatments, such as amphetamines and methylphenidates, are not effective for everyone and are known to have unwanted side effects. While the etiology of the disorder is not yet fully understood, there are clear genetic and environmental components. Nutritional insufficiencies have recently become a popular environmental risk factor under investigation. Essential fatty acids (EFA), omega-3 polyunsaturated fatty acids (PUFA) in particular, are needed for proper brain development and function. Our lab …

Attention Deficit Hyperactivity Disorder: Comparison Of Medication Efficacy And Cost, Robert M. David, Karlen E. Luthy, Janelle L. B. Macintosh, Lacey M. Eden

Student Works

Although a common psychological disorder, pharmacological treatment of Attention Deficit Hyperactivity Disorder can be a costly endeavor. Among 4-5 year olds, methylphenidate is a safe, efficacious, and cost-effective option for short-, intermediate-, and long-acting medication options. Short-acting methylphenidate, intermediate-acting methylphenidate ER and SR, and long-acting methylphenidate LA are the most efficacious and cost-effective medications. Selection of non-stimulant medications should be based upon recommended guidelines rather than primarily on cost. For children incapable of swallowing pills, the most efficacious and cost-effective treatments are short-acting dextroamphetamine liquid and long-acting methylphenidate LA capsules that can be opened and sprinkled over food.

Impulsive Choice In Unmedicated And Medicated Children Diagnosed With Adhd: Examining The Variables Of Reward Type And Adhd Subtype, Nicole Henriksen

Dissertations

Developmentally inappropriate and impairing impulsive behaviors are often seen in attention-deficit/hyperactivity disorder (ADHD). One method for objectively assessing impulsivity is the Choice-Delay Task (C-DT) which presents repeated opportunities to choose between a smaller, sooner (SS) or larger, later (LL) reward. A preference for the SS reward that results in less total reward is considered impulsive. Many studies have found that participants diagnosed with ADHD choose the SS reward more than typical controls. However, less is known about the effects of different types of rewards, or the comparative performance of certain subgroups, such as children diagnosed with ADHD Predominantly Inattentive Type …

Abc Tv's 'Kids On Speed?' Shows Drugs Are Not The Answer, Rae Thomas

Rae Thomas

A recent Australian study found one in five consultations to paediatricians was for attention deficit hyperactivity disorder, with an average diagnostic consultation time of 48 minutes. That doesn’t seem like enough time to comply with the National Health and Medical Research Council’s new Clinical Practice Points on the Diagnosis, Assessment and Management of ADHD in Children and Adolescents.

Dopamine And Glutamate Dysfunction In A Rodent Model Of Attention-Deficit/Hyperactivity Disorder: Implications For Future Neuropharmacology, Erin M. Miller

Theses and Dissertations--Neuroscience

Attention-deficit/hyperactivity disorder (ADHD) is one of the most common disorders of childhood. It is theorized to be caused by catecholamine dysfunction in the striatum (Str) and frontal cortex (FC). The spontaneously hypertensive rat (SHR) has been used as a model for ADHD because of its attention deficits, impulsiveness, and hyperactivity. Prior studies of dopamine (DA) in the Str and FC have revealed conflicting results in the SHR compared to control, indicative of a need for a better understanding of DA dynamics in this model. In addition to the DA hypothesis, studies have begun implicating glutamate in the etiology of ADHD. …

Attention Deficit Hyperactivity Disorder, Other Mental Health Problems, Substance Use And Driving: Examination Of A Population-Based, Representative Canadian Sample, Evelyn R. Vingilis, Robert Mann, Pat Erickson, Maggie Toplak, Nathan Kolla, Jane Seeley, Umesh Jain

Family Medicine Publications

Purpose: The purpose of this study is to examine the relationships among self-reported screening measures of ADHD, other psychiatric problems, and driving-related outcomes in a provincially

representative sample of adults 18 years and older living in the province of Ontario, Canada.

Methods: The study examined the results of the Centre for Addictions and Mental Health (CAMH) Ontario Monitor, an ongoing repeated cross-sectional telephone survey of Ontario adults over a two year period. Measures: ADHD measures (Adult ADHD Self-Report Scale-V1.1 (ASRS-V1.1), previous ADHD diagnosis, ADHD medication use); psychiatric distress measures (General Health Questionnaire (GHQ12), pain, anxiety and depression medication use); antisocial …